Due to medication pricing and regulatory pressures, failed clinical studies, and slow mergers and acquisitions activity, the biotechnology sector has cooled. As of February 17, the SPDR S&P Biotech ETF was down nearly 22% for the year. RBC recently conducted an investor study in the biotech industry. Biotech is expected to outperform the broader market in 2022, according to 66% of respondents. Investors said they would boost their exposure to the sector by 58 percent. In this post, we’ll concentrate on biotech stocks with a market capitalization of less than $5.
Insider Monkey picked the best biotech stocks that were priced under $5. Brickell Biotech, Inc. is based in Boulder, Colorado and was created in 2009. The company’s main goal is to develop treatments for autoimmune, inflammatory, and other dermatological diseases. Brickell biotechnology was given an Outperform rating by William Blair analyst Tim Lugo when he started covering the company. Progenity, Inc. is a biotechnology firm that specializes in molecular testing. Chromosomal abnormalities, preimplantation genetic testing, hereditary diseases, and artificial reproductive technologies are all areas of expertise for the company. Progenity is based in San Diego, California, and was created in 2010. Vaxart, Inc. is a biotechnology company based in California that produces oral vaccinations. COVID-19, influenza, norovirus strains, and respiratory syncytial virus vaccines are all being researched and tested by the company. Gamida Cell Ltd. is a cell therapy company that develops treatments for blood cancers, lymphoma, multiple myeloma, and other hematologic illnesses. With a price of $4.1265, it is one of the top cheap biotech stocks to invest in. Compugen Ltd. is a biotech company that focuses on immuno-oncology clinical trials. Compugen Ltd. was the target of 13 hedge funds in Q4 2021, with a total investment of $55.2 million. For more details, click 10 Best Biotech Stocks Under $5.